Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
NEUROPHET
Neurophet Launches Joint Study with VHIR on ‘Neurophet AQUA MS’, Accelerating AI Algorithm Validation
May 26, 2026
Neurophet Appoints Globally Renowned Imaging AI Expert Dr. Lawrence N. Tanenbaum as Scientific Advisor
May 21, 2026
Neurophet Signs MOU with ALZ-NET to Facilitate Imaging Monitoring Infrastructure for Alzheimer’s Disease Therapies
March 26, 2026
Neurophet Secures FDA 510(k) Clearance for “Neurophet AQUA AD Plus,” Marking Its Third U.S. Regulatory Milestone
February 8, 2026
Neurophet Introduced Use Cases of Its AI-based Brain Imaging Analysis Solutions at the SEACURE Symposium Hosted by Nanyang Technological University in Singapore
December 9, 2025
Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of ‘Neurophet AQUA AD’
December 6, 2025
Neurophet Appoints Josh Cohen, Former Executive from a Global Medical AI firm, as Head of Americas Business — To Accelerate U.S. Market
December 3, 2025
Neurophet and The Florey Strengthen Research Collaboration on ‘Neurophet AQUA’ to Advance Alzheimer’s Disease Diagnosis
November 26, 2025